144 related articles for article (PubMed ID: 26722501)
61. Comparative study of the biological characteristics of mesenchymal stem cells from bone marrow and peripheral blood of rats.
Fu WL; Zhang JY; Fu X; Duan XN; Leung KK; Jia ZQ; Wang WP; Zhou CY; Yu JK
Tissue Eng Part A; 2012 Sep; 18(17-18):1793-803. PubMed ID: 22721583
[TBL] [Abstract][Full Text] [Related]
62. The expression of neurogenic markers after neuronal induction of chorion-derived mesenchymal stromal cells.
Manochantr S; Marupanthorn K; Tantrawatpan C; Kheolamai P
Neurol Res; 2015 Jun; 37(6):545-52. PubMed ID: 25797279
[TBL] [Abstract][Full Text] [Related]
63. Phenotypic and Cytogenetic Characterization of Mesenchymal Stromal Cells in
Rathnayake AJ; Goonasekera HW; Dissanayake VH
Anal Cell Pathol (Amst); 2016; 2016():8012716. PubMed ID: 27660743
[TBL] [Abstract][Full Text] [Related]
64. Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivo.
Jann JC; Mossner M; Riabov V; Altrock E; Schmitt N; Flach J; Xu Q; Nowak V; Obländer J; Palme I; Weimer N; Streuer A; Jawhar A; Darwich A; Jawhar M; Metzgeroth G; Nolte F; Hofmann WK; Nowak D
Nat Commun; 2021 Oct; 12(1):6170. PubMed ID: 34697318
[TBL] [Abstract][Full Text] [Related]
65. Phenotype of mesenchymal stem cells from patients with myelodyplastic syndrome maybe partly modulated by decitabine.
Pang Y; Geng S; Zhang H; Lai P; Liao P; Zeng L; Lu Z; Weng J; Du X
Oncol Lett; 2019 Nov; 18(5):4457-4466. PubMed ID: 31611955
[TBL] [Abstract][Full Text] [Related]
66. Senescence of mesenchymal stem cells (Review).
Li Y; Wu Q; Wang Y; Li L; Bu H; Bao J
Int J Mol Med; 2017 Apr; 39(4):775-782. PubMed ID: 28290609
[TBL] [Abstract][Full Text] [Related]
67. Bone marrow mesenchymal stromal cell-derived extracellular matrix displays altered glycosaminoglycan structure and impaired functionality in Myelodysplastic Syndromes.
Bains AK; Behrens Wu L; Rivière J; Rother S; Magno V; Friedrichs J; Werner C; Bornhäuser M; Götze KS; Cross M; Platzbecker U; Wobus M
Front Oncol; 2022; 12():961473. PubMed ID: 36158640
[TBL] [Abstract][Full Text] [Related]
68. Premature exhaustion of mesenchymal stromal cells from myelodysplastic syndrome patients.
Pang Y; Deng C; Geng S; Weng J; Lai P; Liao P; Zeng L; Lu Z; Zhang J; Du X
Am J Transl Res; 2017; 9(7):3462-3468. PubMed ID: 28804562
[TBL] [Abstract][Full Text] [Related]
69. No telomere shortening in marrow stroma from patients with MDS.
Marcondes AM; Bair S; Rabinovitch PS; Gooley T; Deeg HJ; Risques R
Ann Hematol; 2009 Jul; 88(7):623-8. PubMed ID: 19050887
[TBL] [Abstract][Full Text] [Related]
70. The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes.
Zhao Z; Wang Z; Li Q; Li W; You Y; Zou P
PLoS One; 2012; 7(9):e45675. PubMed ID: 23029178
[TBL] [Abstract][Full Text] [Related]
71. MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes.
Giallongo C; Dulcamare I; Giallongo S; Duminuco A; Pieragostino D; Cufaro MC; Amorini AM; Lazzarino G; Romano A; Parrinello N; Di Rosa M; Broggi G; Caltabiano R; Caraglia M; Scrima M; Pasquale LS; Tathode MS; Li Volti G; Motterlini R; Di Raimondo F; Tibullo D; Palumbo GA
Cell Death Dis; 2023 Oct; 14(10):686. PubMed ID: 37852977
[TBL] [Abstract][Full Text] [Related]
72. Sequential gene expression analysis of myelodysplastic syndrome transformation identifies HOXB3 and HOXB7 as the novel targets for mesenchymal cells in disease.
Yin C; Li Y; Zhang C; Zang S; Wang Z; Yan X; Ma T; Li X; Li W
BMC Cancer; 2024 Jan; 24(1):111. PubMed ID: 38254070
[TBL] [Abstract][Full Text] [Related]
73. Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro.
Redondo J; Sarkar P; Kemp K; Virgo PF; Pawade J; Norton A; Emery DC; Guttridge MG; Marks DI; Wilkins A; Scolding NJ; Rice CM
Mult Scler; 2018 Jun; 24(7):919-931. PubMed ID: 28548004
[TBL] [Abstract][Full Text] [Related]
74. Myelodysplastic syndromes disable human CD271+VCAM1+CD146+ niches supporting normal hematopoietic stem/progenitor cells.
Kawano Y; Kawano H; Ghoneim D; Fountaine TJ; Byun DK; LaMere MW; Mendler JH; Ho TC; Salama NA; Myers JR; Hussein SE; Frisch BJ; Ashton JM; Azadniv M; Liesveld JL; Kfoury Y; Scadden DT; Becker MW; Calvi LM
bioRxiv; 2023 Apr; ():. PubMed ID: 37066307
[TBL] [Abstract][Full Text] [Related]
75. Senescent Mesenchymal Stem Cells in Myelodysplastic Syndrome: Functional Alterations, Molecular Mechanisms, and Therapeutic Strategies.
Chen X; Li N; Weng J; Du X
Front Cell Dev Biol; 2020; 8():617466. PubMed ID: 33644035
[TBL] [Abstract][Full Text] [Related]
76. Proliferation Pattern of Pediatric Tumor-Derived Mesenchymal Stromal Cells and Role in Cancer Dormancy: A Perspective of Study for Surgical Strategy.
Pelizzo G; Riva F; Croce S; Avanzini MA; Acquafredda G; de Silvestri A; Mazzon E; Bramanti P; Zuccotti G; Mazzini G; Calcaterra V
Front Pediatr; 2021; 9():766610. PubMed ID: 34805051
[TBL] [Abstract][Full Text] [Related]
77. Iron Overload Impairs Bone Marrow Mesenchymal Stromal Cells from Higher-Risk MDS Patients by Regulating the ROS-Related Wnt/
Huang L; Liu Z; Liu H; Ding K; Mi F; Xiang C; Wang G; Guo Y; Fu R
Stem Cells Int; 2020; 2020():8855038. PubMed ID: 33178287
[TBL] [Abstract][Full Text] [Related]
78. The Brazilian Pediatric Myelodysplastic Cooperative Group strategies: are they relevant to improve educational approach and correct diagnosis?
Lopes LF; Lorand-Metze I; Niero-Melo L; Tone LG; Velloso E; Campanaro CM; Latorre Mdo R
Leuk Res; 2002 Jul; 26(7):637-42. PubMed ID: 12008080
[TBL] [Abstract][Full Text] [Related]
79. Low-Dose Pesticides Alter Primary Human Bone Marrow Mesenchymal Stem/Stromal Cells through ALDH2 Inhibition.
Foucault A; Ravalet N; Besombes J; Picou F; Gallay N; Babin L; Bourgeais J; Hamard S; Domenech J; Loyer P; Vallet N; Lejeune J; Gyan E; Béné MC; Vallette F; Olivier C; Hérault O
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830855
[TBL] [Abstract][Full Text] [Related]
80. Disease progression in myelodysplastic syndromes: do mesenchymal cells pave the way?
Raaijmakers MH
Cell Stem Cell; 2014 Jun; 14(6):695-7. PubMed ID: 24905157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
